Kagenori Ito

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 5

Top Topics

Prostate Cancer

Cell Cycle Arrest

Induced Apoptosis

Mycobacterium Tuberculosis

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Nobuyoshi Kosaka, Nobuyoshi Kosaka, Yurika Sawa, Yusuke Yamamoto, Kagenori Ito, Tomofumi Yamamoto, Takahiro Kimura, Shin Egawa, Takahiro Ochiya
miR-26a regulates extracellular vesicle secretion from prostate cancer cells via targeting SHC4, PFDN4, and CHORDC1. Science advances 6 (18) (2020)
Nobuyoshi Kosaka, Nobuyoshi Kosaka, Yurika Sawa, Kagenori Ito, Takahiro Kimura, Shin Egawa, Takahiro Ochiya, Yusuke Yamamoto
The miR-1908/SRM regulatory axis contributes to extracellular vesicle secretion in prostate cancer. Cancer science 111 (9) (2020)
Junichiro Chikuda, Kurataka Otsuka, Iwao Shimomura, Kagenori Ito, Hiroaki Miyazaki, Ryou-U Takahashi, Masahiro Nagasaki, Yoshiki Mukudai, Takahiro Ochiya, Toshikazu Shimane, Tatsuo Shirota, Yusuke Yamamoto
CD44s Induces miR-629-3p Expression in Association with Cisplatin Resistance in Head and Neck Cancer Cells. Cancers 12 (4) (2020)
Masatoshi Tanaka, Takahiro Kimura, Yumina Iwamura, Yuki Enei, Yuya Iwamoto, Yu Imai, Yuzo Inaba, Akihiro Matsukawa, Hajime Onuma, Kagenori Ito, Keiichiro Mori, Hiroshi Sasaki, Jun Miki, Akira Furuta, Kenta Miki, Shin Egawa
No survival benefit found after extended treatment with docetaxel for patients with castration-resistant prostate cancer. The Prostate 79 (14) (2019)
Kagenori Ito, Takahiro Kimura, Hajime Onuma, Ryuji Tabata, Tatsuya Shimomura, Kenta Miki, Masayuki Tomita, Shin Egawa
Does docetaxel prolong survival of patients with non-metastatic castration-resistant prostate cancer? The Prostate 78 (7) (2018)